Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient

Area of Science:

• Neuroimmunology
• Viral Hepatitis
• Retroviral Infections

Background:

• Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system.
• HIV/HCV co-infection and cirrhosis are known risk factors for PML.
• Maintaining viral suppression and adequate CD4 counts in HIV patients is crucial for preventing opportunistic infections.

Observation:

• A case of a patient with HIV/HCV co-infection and cirrhosis who developed PML.
• The patient had maintained HIV suppression and a CD4 cell count above 250/mm³ for two years prior to PML onset.
• Immunological studies revealed a decrease in naïve CD4 cells and NK lymphopenia with abnormal NK cell activity.

Findings:

• Impaired T-cell and NK-cell immunity was observed in the patient during PML.
• The specific immunological deficits included a reduction in naïve CD4+ T cells and atypical NK cell populations.
• These immune alterations occurred despite effective control of HIV replication.

Implications:

• The findings suggest that complex interactions between HIV, HCV, and cirrhosis may lead to immune dysfunction that increases PML risk.
• Further research is needed to understand the precise mechanisms of immune impairment in co-infected patients.
• This case underscores the importance of vigilant monitoring for opportunistic infections like PML in patients with advanced liver disease and co-infections.